Published in Int J Pharm Pract on December 06, 2013
Microneedles: A New Frontier in Nanomedicine Delivery. Pharm Res (2016) 0.82
A facile system to evaluate in vitro drug release from dissolving microneedle arrays. Int J Pharm (2015) 0.80
The Use of a Pressure-Indicating Sensor Film to Provide Feedback upon Hydrogel-Forming Microneedle Array Self-Application In Vivo. Pharm Res (2016) 0.78
Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother (2008) 1.87
Societal perspectives on over-the-counter (OTC) medicines. Fam Pract (2005) 1.73
Pharmacists' perceptions of their professional role: insights into hospital pharmacy culture. Can J Hosp Pharm (2011) 1.72
Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano (2013) 1.58
Pharmacokinetics of melatonin in preterm infants. Br J Clin Pharmacol (2013) 1.48
Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J Pharm Pharmacol (2011) 1.27
Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol (2012) 1.25
Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother (2009) 1.22
Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res (2011) 1.21
Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol (2009) 1.20
An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother (2012) 1.20
Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. Pediatrics (2011) 1.18
Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci (2013) 1.18
Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches. J Pharm Sci (2013) 1.17
Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. Toxicol In Vitro (2010) 1.10
Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci (2003) 1.07
Public perceptions of coronary events risk factors: a discrete choice experiment. BMJ Open (2012) 1.07
Mucoadhesive drug delivery systems. J Pharm Bioallied Sci (2011) 1.07
Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol (2009) 1.06
Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect Control Hosp Epidemiol (2011) 1.06
Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci (2010) 1.05
An innovative approach to integrated medicines management. J Eval Clin Pract (2007) 1.05
The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Educ Couns (2005) 1.03
Help needed in medication self-management for people with visual impairment: case-control study. Br J Gen Pract (2012) 1.01
Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension--a primary care study. Patient Educ Couns (2008) 0.99
Anti-adherent and antifungal activities of surfactant-coated poly(ethylcyanoacrylate) nanoparticles. Int J Pharm (2007) 0.98
Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant. Br J Clin Pharmacol (2009) 0.98
Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays. Int J Pharm (2012) 0.96
The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol (2012) 0.96
Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Release (2012) 0.96
Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine. Br J Clin Pharmacol (2008) 0.95
Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia. Br J Clin Pharmacol (2008) 0.95
Pharmaceutical care programmes for the elderly: economic issues. Pharmacoeconomics (2003) 0.95
Drug delivery strategies for photodynamic antimicrobial chemotherapy: from benchtop to clinical practice. J Photochem Photobiol B (2009) 0.95
Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv (2012) 0.94
Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine (2012) 0.93
Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol (2011) 0.93
Physical characterisation and component release of poly(vinyl alcohol)-tetrahydroxyborate hydrogels and their applicability as potential topical drug delivery systems. Int J Pharm (2011) 0.93
Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. J Microencapsul (2006) 0.93
Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: a pilot study. Pharm World Sci (2004) 0.92
Effects of an integrated medicines management program on medication appropriateness in hospitalized patients. Am J Health Syst Pharm (2009) 0.92
Coronary heart disease: health knowledge and behaviour. Int J Clin Pharm (2011) 0.92
Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm (2011) 0.91
Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul (2010) 0.91
Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin Drug Deliv (2008) 0.91
Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments. Future Med Chem (2009) 0.91
Review of patents on microneedle applicators. Recent Pat Drug Deliv Formul (2011) 0.90
Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough? Curr Opin Infect Dis (2012) 0.90
The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia--an exploratory study. Eur J Clin Pharmacol (2009) 0.89
Investigation of solute permeation across hydrogels composed of poly(methyl vinyl ether-co-maleic acid) and poly(ethylene glycol). J Pharm Pharmacol (2010) 0.88
Electrically enhanced solute permeation across poly(ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: effect of hydrogel crosslink density and ionic conductivity. Int J Pharm (2011) 0.88
Development and validation of a dried blood spot-HPLC assay for the determination of metronidazole in neonatal whole blood samples. Anal Bioanal Chem (2010) 0.88
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol (2012) 0.88
The journey to concordance for patients with hypertension: a qualitative study in primary care. Pharm World Sci (2007) 0.87
Comparison of tools for the assessment of inappropriate prescribing in hospitalized older people. J Eval Clin Pract (2011) 0.87
Microneedle arrays as medical devices for enhanced transdermal drug delivery. Expert Rev Med Devices (2011) 0.87
The role of microneedles for drug and vaccine delivery. Expert Opin Drug Deliv (2014) 0.87
Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium. Eur J Pharm Biopharm (2012) 0.87
Microneedle-mediated minimally invasive patient monitoring. Ther Drug Monit (2014) 0.86
Development of novel oral formulations prepared via hot melt extrusion for targeted delivery of photosensitizer to the colon. Photochem Photobiol (2011) 0.86
Associations between maternal characteristics and pregnancy-related stress among low-risk mothers: an observational cross-sectional study. Int J Nurs Stud (2010) 0.86
Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing. Int J Clin Pharm (2011) 0.85
Pharmaceutical care of patients with gestational diabetes mellitus. J Eval Clin Pract (2008) 0.85
The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Educ Couns (2006) 0.85
Photodynamic Antimicrobial Chemotherapy (PACT) in combination with antibiotics for treatment of Burkholderia cepacia complex infection. J Photochem Photobiol B (2011) 0.85
Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res (2015) 0.85
Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticles. Pharm Res (2007) 0.85
Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. J Control Release (2012) 0.85
Effect of sub-lethal challenge with Photodynamic Antimicrobial Chemotherapy (PACT) on the antibiotic susceptibility of clinical bacterial isolates. J Photochem Photobiol B (2010) 0.85
Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles. Biomacromolecules (2013) 0.84
Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. J Biomed Mater Res A (2008) 0.84
Pharmacists' perceptions of their practice: a comparison between Alberta and Northern Ireland. Int J Pharm Pract (2011) 0.84
What the newspapers say about medication adherence: a content analysis. BMC Public Health (2013) 0.84
Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B (2010) 0.84
Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant. Expert Opin Drug Saf (2010) 0.83
Development and validation of an HPLC method for the rapid and simultaneous determination of 6-mercaptopurine and four of its metabolites in plasma and red blood cells. J Pharm Biomed Anal (2008) 0.83
Microneedle-mediated transdermal bacteriophage delivery. Eur J Pharm Sci (2012) 0.83
Modulation of gel formation and drug-release characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars. Eur J Pharm Biopharm (2008) 0.83
Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study. Exp Dermatol (2004) 0.83
A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin Pharmacol (2011) 0.83
Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination. J Pharm Pharmacol (2014) 0.83
Paediatricians' opinions of microneedle-mediated monitoring: a key stage in the translation of microneedle technology from laboratory into clinical practice. Drug Deliv Transl Res (2015) 0.82
Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework. Pharm World Sci (2009) 0.82
Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected. J Pharm Sci (2014) 0.82
Children's views on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol (2011) 0.82
Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res (2015) 0.82
Development and validation of a dried blood spot-LC-APCI-MS assay for estimation of canrenone in paediatric samples. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.82
Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions. Eur J Pharm Sci (2005) 0.81
Strategies for enhanced peptide and protein delivery. Ther Deliv (2013) 0.81
Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling. Epilepsia (2013) 0.81
Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis. Biomaterials (2004) 0.80
Determination of diclofenac from paediatric urine samples by stir bar sorptive extraction (SBSE)-HPLC-UV technique. Talanta (2011) 0.80
Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: methodology and assay validation. J Pharm Biomed Anal (2005) 0.80
Public knowledge and perceptions of connected health. J Eval Clin Pract (2014) 0.80
In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch. Eur J Pharm Biopharm (2006) 0.80
Evaluation of the efficacy of a conventional cleaning regimen in removing methicillin-resistant Staphylococcus aureus from contaminated surfaces in an intensive care unit. Infect Control Hosp Epidemiol (2009) 0.79
Dried blood spot assay for estimation of metronidazole concentrations in rats and its application in single animal drug pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.79
Microneedles: an innovative platform for gene delivery. Drug Deliv Transl Res (2015) 0.79